Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Simulations Plus, Inc. - Common Stock (NQ:SLP)

18.24 -0.01 (-0.05%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Simulations Plus, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Halper Sadeh LLC is Investigating Whether SLP, LPRO, HUN are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Simulations Plus, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – SLP
From DJS Law Group
Via Business Wire
News headline image
Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Halper Sadeh LLC is Investigating Whether SLP, ROKU, TBRG are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm
From Schall Law Firm
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG), Organon & Co. (NYSE – OGN)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
SLP Stock Alert: Halper Sadeh LLC is Investigating Whether Simulations Plus, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Simulations Plus to Be Acquired by Altaris For Approximately $375 Million
From Simulations Plus, Inc.
Via Business Wire
News headline image
SLP INVESTIGATION ALERT: Johnson Fistel Continues Investigation of Simulations Plus, Inc. Following Guidance Cut, Impairment Charge, and Auditor Disclosures
From Johnson Fistel, PLLP
Via Business Wire
News headline image
Simulations Plus, Inc. (SLP) Securities Fraud Investigation: Johnson Fistel Investigates Investor Losses Following Revenue Outlook Revision, Impairment Charge, and Auditor Dispute
From Johnson Fistel, PLLP
Via Business Wire
News headline image
Robbins LLP is Investigating Allegations that the Officers and Directors of Simulations Plus, Inc. (SLP) Violated Securities Laws and Breached Fiduciary Duties to Shareholders
From Robbins LLP
Via Business Wire
News headline image
Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus to Participate in Upcoming Investor Conferences
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Positioned to Capitalize on FDA’s Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results
From Simulations Plus, Inc.
Via Business Wire
News headline image
SIMULATIONS PLUS INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Simulations Plus Investors to Contact the Firm Regarding Their Rights
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance
From Simulations Plus, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.